Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMEDISYS INCAMED · Entity 16075 | Chief People Officer | February 16, 2024 | February 21, 2024 |
| GE HealthCare Technologies Inc.GEHC · Entity 1711 | Chief People Officer | September 03, 2026 | September 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMEDISYS INC
Report date February 16, 2024 · Filed February 21, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,863 |
Reported balance
After 2024-02-16 transaction · row 1
1 source rowRow 1 · 2024-02-16 · Grant · Acquired 5,518 · Balance 10,863 F1: The Issuer awarded the Reporting Person 5,518 time-based RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock, and will vest in equal, 1/4 installments on each of February 16, 2025, 2026, 2027 and 2028, provided that the Reporting Person remains continuously employed by the Issuer on each such date. |
Filing footnotes · ownership attribution and instrument terms
F1: The Issuer awarded the Reporting Person 5,518 time-based RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock, and will vest in equal, 1/4 installments on each of February 16, 2025, 2026, 2027 and 2028, provided that the Reporting Person remains continuously employed by the Issuer on each such date.
GE HealthCare Technologies Inc.
Report date September 03, 2026 · Filed September 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 19,533 |
Reported balance
After 2026-09-03 transaction · row 1
1 source rowRow 1 · 2026-09-03 · Tax withholding · Disposed 673 · Balance 19,533 F1: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 03, 2026 Filed Sep 4, 2026 20:41 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 673 | $70.56 | $47,486.88 |
DisclosureSEC source: 0001657919-26-000009 · wk-form4_1788554494.xml · nonDerivative · entry 1 Holton Adam Y · CIK 0001657919 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,533 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:17 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 659 | $71.23 | $46,940.57 |
DisclosureSEC source: 0001657919-26-000007 · wk-form4_1788466636.xml · nonDerivative · entry 1 Holton Adam Y · CIK 0001657919 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,206 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| August 15, 2026 Filed Aug 18, 2026 20:14 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 1,360 | $73.69 | $100,218.40 |
DisclosureSEC source: 0001657919-26-000004 · wk-form4_1787084055.xml · nonDerivative · entry 1 Holton Adam Y · CIK 0001657919 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,865 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:25 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 14,348 | $0.00 Strike: $80.16 | $0.00 |
DisclosureSEC source: 0001657919-26-000002 · wk-form4_1772659548.xml · derivative · entry 2 Holton Adam Y · CIK 0001657919 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,348 Underlying: Common Stock, par value $0.01 per share · 14,348 shares Expires 2036-03-02 F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:25 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 5,457 | $0.00 | $0.00 |
DisclosureSEC source: 0001657919-26-000002 · wk-form4_1772659548.xml · nonDerivative · entry 1 Holton Adam Y · CIK 0001657919 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,225 F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock. F2 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 20:18 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 464 | $73.73 | $34,210.72 |
DisclosureSEC source: 0001657919-25-000009 · wk-form4_1756930716.xml · nonDerivative · entry 1 Holton Adam Y · CIK 0001657919 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,768 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 03, 2025 Filed Mar 6, 2025 00:32 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 12,404 | $0.00 Strike: $86.45 | $0.00 |
DisclosureSEC source: 0001628280-25-010689 · wk-form4_1741221114.xml · derivative · entry 2 Holton Adam Y · CIK 0001657919 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,404 Underlying: Common Stock, par value $0.01 per share · 12,404 shares Expires 2035-03-03 F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028, subject to certain conditions. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028, subject to certain conditions. Read SEC document |
| March 03, 2025 Filed Mar 6, 2025 00:32 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 4,337 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-010689 · wk-form4_1741221114.xml · nonDerivative · entry 1 Holton Adam Y · CIK 0001657919 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,232 F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock. F2 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 3, 2026, 33% will vest on September 3, 2027, and 34% will vest on September 3, 2028. Read SEC document |
| August 15, 2024 Filed Aug 19, 2024 20:16 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 13,293 | $0.00 Strike: $85.30 | $0.00 |
DisclosureSEC source: 0001628280-24-037704 · wk-form4_1724098594.xml · derivative · entry 3 Holton Adam Y · CIK 0001657919 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,293 Underlying: Common Stock, par value $0.01 per share · 13,293 shares Expires 2034-08-15 F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions. F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions. Read SEC document |
| August 15, 2024 Filed Aug 19, 2024 20:16 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 8,499 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-037704 · wk-form4_1724098594.xml · nonDerivative · entry 2 Holton Adam Y · CIK 0001657919 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,895 F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. F3 · shares: Award of restricted stock with respect to GE HealthCare common stock, of which 50% will vest on August 15, 2026, and 50% will vest on August 15, 2027, subject to certain conditions. Read SEC document |
| August 15, 2024 Filed Aug 19, 2024 20:16 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 4,396 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-037704 · wk-form4_1724098594.xml · nonDerivative · entry 1 Holton Adam Y · CIK 0001657919 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,396 F1 · shares: Award of restricted stock with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 33% will vest on September 1, 2025, 33% will vest on September 1, 2026, and 34% will vest on September 1, 2027, subject to certain conditions. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 21:02 UTC | AMEDISYS INC AMED · Entity 16075 | GrantCommon Stock | 5,518 | $0.00 | $0.00 |
DisclosureSEC source: 0000896262-24-000010 · wk-form4_1708567355.xml · nonDerivative · entry 1 Holton Adam Y · CIK 0001657919 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,863 F1 · shares: The Issuer awarded the Reporting Person 5,518 time-based RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock, and will vest in equal, 1/4 installments on each of February 16, 2025, 2026, 2027 and 2028, provided that the Reporting Person remains continuously employed by the Issuer on each such date. Read SEC document |
| December 21, 2023 Filed Dec 26, 2023 21:00 UTC | AMEDISYS INC AMED · Entity 16075 | Tax withholdingCommon Stock | 690 | $95.54 | $65,922.60 |
DisclosureSEC source: 0000896262-23-000080 · wk-form4_1703642394.xml · nonDerivative · entry 1 Holton Adam Y · CIK 0001657919 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,345 F1 · shares: Reflects shares withheld upon accelerated vesting of certain outstanding time-based restricted stock units ("RSUs"). The RSUs were accelerated from February 2024 and October 2024 to December 21, 2023 in order to mitigate impacts that could arise under Sections 280G and 4999 of the Internal Revenue Code of 1986, as amended. The Reporting Person has signed a letter agreement providing that such accelerated RSUs are subject to certain forfeiture conditions. Read SEC document |
| October 20, 2023 Filed Oct 24, 2023 19:04 UTC | AMEDISYS INC AMED · Entity 16075 | Tax withholdingCommon Stock | 509 | $92.74 | $47,204.66 |
DisclosureSEC source: 0000896262-23-000074 · wk-form4_1698188681.xml · nonDerivative · entry 1 Holton Adam Y · CIK 0001657919 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,035 Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 21:21 UTC | AMEDISYS INC AMED · Entity 16075 | GrantRestricted Stock Unit (Performance-Based Vesting) · Derivative | 2,725 | $0.00 | $0.00 |
DisclosureSEC source: 0000896262-23-000025 · wf-form4_167755087118268.xml · derivative · entry 3 Holton Adam Y · CIK 0001657919 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,725 Underlying: Common Stock · 2,725 shares Expires not disclosed F3 · derivative.exercise_price: The performance-based RSUs will cliff vest following a three-year performance period ending December 31, 2025 based on the Company's achievement of a pre-established performance measure for 2023, as modified by the Company's three-year total shareholder return percentile rank compared to a pre-established comparator group. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0% to 200% of the amount reported depending on the level of performance achieved. F3 · derivative.exercise_date: The performance-based RSUs will cliff vest following a three-year performance period ending December 31, 2025 based on the Company's achievement of a pre-established performance measure for 2023, as modified by the Company's three-year total shareholder return percentile rank compared to a pre-established comparator group. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0% to 200% of the amount reported depending on the level of performance achieved. F3 · derivative.expiration_date: The performance-based RSUs will cliff vest following a three-year performance period ending December 31, 2025 based on the Company's achievement of a pre-established performance measure for 2023, as modified by the Company's three-year total shareholder return percentile rank compared to a pre-established comparator group. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0% to 200% of the amount reported depending on the level of performance achieved. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 21:21 UTC | AMEDISYS INC AMED · Entity 16075 | GrantStock Option (Right to Buy) · Derivative | 2,876 | $0.00 Strike: $91.77 | $0.00 |
DisclosureSEC source: 0000896262-23-000025 · wf-form4_167755087118268.xml · derivative · entry 2 Holton Adam Y · CIK 0001657919 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,876 Underlying: Common Stock · 2,876 shares Expires 2033-02-23 F2 · derivative.exercise_date: The Stock Options are subject to time-based vesting conditions and will vest in equal, 1/3 installments on each of February 20, 2024, 2025 and 2026, provided that the Reporting Person remains continuously employed by the Issuer on each such date. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 21:21 UTC | AMEDISYS INC AMED · Entity 16075 | GrantCommon Stock | 1,363 | $0.00 | $0.00 |
DisclosureSEC source: 0000896262-23-000025 · wf-form4_167755087118268.xml · nonDerivative · entry 1 Holton Adam Y · CIK 0001657919 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,544 F1 · shares: The Issuer awarded the Reporting Person 1,363 time-based RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock, and will vest in equal, 1/3 installments on each of February 20, 2024, 2025 and 2026, provided that the Reporting Person remains continuously employed by the Issuer on each such date. Read SEC document |
| October 20, 2022 Filed Oct 24, 2022 16:03 UTC | AMEDISYS INC AMED · Entity 16075 | GrantCommon Stock | 5,181 | $0.00 | $0.00 |
DisclosureSEC source: 0000896262-22-000058 · wf-form4_166664178625249.xml · nonDerivative · entry 1 Holton Adam Y · CIK 0001657919 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,181 F1 · shares: The Issuer awarded the Reporting Person 5,181 time-based restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock, and will vest in equal, 25% installments on each of October 20, 2023, 2024, 2025 and 2026, provided that the Reporting Person remains continuously employed by the Issuer on each such date, subject to certain pro-rated vesting provisions as provided in the award agreement for the RSUs. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.